Parts matching “Retina” · all types
Synthetic AAV promoter engineered for cone photoreceptor-specific expression, selected from a computationally designed library of retinal promoters. Drives GFP reporter expression predominantly in cones in mouse retina, and with near-complete specificity for cones in ex vivo non-human primate and human retina.
Synthetic AAV promoter assembled from previously characterized, low-methylation cis-regulatory elements and selected for cone-photoreceptor-restricted expression. The most effective cone-specific promoter identified from a library of 230 synthetic candidates, labeling roughly 83% of adult cones in the mouse retina with no detected rod expression, and validated in mouse, non-human primate, and human retina.
Mouse mGluR6 (Grm6) short promoter (shGRM6, 0.7 kb) combining a 200-bp mGluR6 distal enhancer with a 500-bp endogenous mGluR6 core promoter fragment. Drives AAV-mediated transgene expression selectively in retinal ON/rod bipolar cells, replacing the heterologous SV40 minimal promoter used in earlier mGluR6 constructs.
Composite mouse Grm6 (mGluR6) regulatory cassette combining shortened intron 4 and intron 3 enhancer sequences with the core 200 bp Grm6 enhancer and a 500 bp proximal Grm6 promoter, giving markedly stronger and more selective AAV-mediated expression in retinal ON bipolar cells than the minimal 200 bp enhancer/SV40 cassette (grm6).
Natural serotype with unique receptor usage and distinct tropism profile. Notable for lower pre-existing immunity and efficient CNS transduction.
AAV-optimized cytosine base editor with enhanced nuclear localization and codon usage. Enables dual-AAV delivery for in vivo therapeutic applications.
Compact SaCas9-based cytosine editor split via Npu intein for dual-AAV delivery. Smaller size than SpCas9 enables efficient packaging.
N-terminal fragment of ABE7.10 split via Npu intein at E573. Requires C-terminal counterpart for reconstitution.
N-terminal fragment of cytosine base editor split via Npu intein at E573. Requires C-terminal counterpart for reconstitution.
Human bestrophin-1 (BEST1, formerly VMD2) gene promoter, restricted to the retinal pigment epithelium (RPE). A short proximal fragment is sufficient to direct RPE-specific expression in the eyes of transgenic mice. Packaged in AAV vectors, it targets BEST1 or reporter transgenes to RPE cells for gene therapy of Best vitelliform macular dystrophy.
Optimized SaCas9-KKH base editor with enhanced nuclear localization and NNNRRT PAM. Combines BE3.9max improvements with broader targeting.
N-terminal fragment of SaCas9-based cytosine editor split via Npu intein at Lys534. Compact size enables efficient AAV packaging.
C-terminal fragment of optimized SaCas9 base editor split via Npu intein at Cys535. Pairs with N-terminal for high-efficiency editing.
N-terminal fragment of optimized SaCas9 base editor split via Npu intein at Lys534. Combines compact size with enhanced expression.
Proximal promoter region of the human rhodopsin (RHO) gene, restricting expression to rod photoreceptors of the retina. Used in AAV vectors combining RHO-targeted knockdown with mutation-independent RHO replacement for gene therapy of rhodopsin-linked autosomal dominant retinitis pigmentosa.